These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
307 related items for PubMed ID: 9648634
1. Internal jugular venous spillover of noradrenaline and metabolites and their association with sympathetic nervous activity. Lambert GW, Kaye DM, Thompson JM, Turner AG, Cox HS, Vaz M, Jennings GL, Wallin BG, Esler MD. Acta Physiol Scand; 1998 Jun; 163(2):155-63. PubMed ID: 9648634 [Abstract] [Full Text] [Related]
2. Jugular venous overflow of noradrenaline from the brain: a neurochemical indicator of cerebrovascular sympathetic nerve activity in humans. Mitchell DA, Lambert G, Secher NH, Raven PB, van Lieshout J, Esler MD. J Physiol; 2009 Jun 01; 587(Pt 11):2589-97. PubMed ID: 19403604 [Abstract] [Full Text] [Related]
3. Cerebral noradrenaline spillover and its relation to muscle sympathetic nervous activity in healthy human subjects. Lambert GW, Thompson JM, Turner AG, Cox HS, Wilkinson D, Vaz M, Kalff V, Kelly MJ, Jennings GL, Esler MD. J Auton Nerv Syst; 1997 May 12; 64(1):57-64. PubMed ID: 9188086 [Abstract] [Full Text] [Related]
4. Adrenaline infusion in man increases muscle sympathetic nerve activity and noradrenaline overflow to plasma. Persson B, Andersson OK, Hjemdahl P, Wysocki M, Agewall S, Wallin G. J Hypertens; 1989 Sep 12; 7(9):747-56. PubMed ID: 2551959 [Abstract] [Full Text] [Related]
5. Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients. Lambert GW, Kaye DM, Lefkovits J, Jennings GL, Turner AG, Cox HS, Esler MD. Circulation; 1995 Oct 01; 92(7):1813-8. PubMed ID: 7545554 [Abstract] [Full Text] [Related]
6. Central nervous system monoamine neurotransmitter turnover in primary and obesity-related human hypertension. Esler M, Lambert G, Vaz M, Thompson J, Kaye D, Kalff V, Kelly M, Turner A, Jennings G. Clin Exp Hypertens; 1997 Oct 01; 19(5-6):577-90. PubMed ID: 9247740 [Abstract] [Full Text] [Related]
7. Noradrenaline spillover and microneurography measurements in patients with primary hypertension. Jennings GL. J Hypertens Suppl; 1998 Aug 01; 16(3):S35-8. PubMed ID: 9747908 [Abstract] [Full Text] [Related]
8. Central nervous system noradrenergic control of sympathetic outflow in normotensive and hypertensive humans. Esler MD, Lambert GW, Ferrier C, Kaye DM, Wallin BG, Kalff V, Kelly MJ, Jennings GL. Clin Exp Hypertens; 1995 Aug 01; 17(1-2):409-23. PubMed ID: 7735286 [Abstract] [Full Text] [Related]
9. Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice. Esler M, Lambert G, Brunner-La Rocca HP, Vaddadi G, Kaye D. Acta Physiol Scand; 2003 Mar 01; 177(3):275-84. PubMed ID: 12608997 [Abstract] [Full Text] [Related]
10. The influence of aging on the human sympathetic nervous system and brain norepinephrine turnover. Esler M, Hastings J, Lambert G, Kaye D, Jennings G, Seals DR. Am J Physiol Regul Integr Comp Physiol; 2002 Mar 01; 282(3):R909-16. PubMed ID: 11832414 [Abstract] [Full Text] [Related]
11. Human muscle sympathetic activity and cardiac catecholamine spillover: no support for augmented sympathetic noradrenaline release by adrenaline co-transmission. Thompson JM, Wallin BG, Lambert GW, Jennings GL, Esler MD. Clin Sci (Lond); 1998 Apr 01; 94(4):383-93. PubMed ID: 9640344 [Abstract] [Full Text] [Related]
12. Differentiation in the effects of the angiotensin II receptor blocker class on autonomic function. Esler M. J Hypertens Suppl; 2002 Jun 01; 20(5):S13-9. PubMed ID: 12184059 [Abstract] [Full Text] [Related]
13. High blood pressure management: potential benefits of I1 agents. Esler M. J Hypertens Suppl; 1998 Aug 01; 16(3):S19-24. PubMed ID: 9747906 [Abstract] [Full Text] [Related]
14. Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure. Esler M, Kaye D. J Auton Nerv Syst; 1998 Oct 15; 72(2-3):210-9. PubMed ID: 9851571 [Abstract] [Full Text] [Related]
15. Microneurography: a technique for assessing central neural effects of adrenergic drugs on sympathetic outflow in humans. Mark AL, Wallin BG. J Cardiovasc Pharmacol; 1985 Oct 15; 7 Suppl 8():S67-9. PubMed ID: 2417051 [Abstract] [Full Text] [Related]
16. Cerebral metabolism and its relationship with sympathetic nervous activity in essential hypertension: evaluation of the Dickinson hypothesis. Lambert GW, Vaz M, Rajkumar C, Cox HS, Turner AG, Jennings GL, Esler MD. J Hypertens; 1996 Aug 15; 14(8):951-9. PubMed ID: 8884549 [Abstract] [Full Text] [Related]
17. Norepinephrine turnover is increased in suprabulbar subcortical brain regions and is related to whole-body sympathetic activity in human heart failure. Aggarwal A, Esler MD, Lambert GW, Hastings J, Johnston L, Kaye DM. Circulation; 2002 Mar 05; 105(9):1031-3. PubMed ID: 11877349 [Abstract] [Full Text] [Related]
18. Increased norepinephrine spillover into the jugular veins in essential hypertension. Ferrier C, Esler MD, Eisenhofer G, Wallin BG, Horne M, Cox HS, Lambert G, Jennings GL. Hypertension; 1992 Jan 05; 19(1):62-9. PubMed ID: 1730441 [Abstract] [Full Text] [Related]
19. Plasma noradrenaline correlates to sympathetic muscle nerve activity in normotensive man. Wallin BG, Sundlöf G, Eriksson BM, Dominiak P, Grobecker H, Lindblad LE. Acta Physiol Scand; 1981 Jan 05; 111(1):69-73. PubMed ID: 7223453 [Abstract] [Full Text] [Related]
20. Sympathetic activity and presynaptic adrenoceptor function in patients with longstanding essential hypertension. Chang PC, Kriek E, van Brummelen P. J Hypertens; 1994 Feb 05; 12(2):179-90. PubMed ID: 8021470 [Abstract] [Full Text] [Related] Page: [Next] [New Search]